Jih Ru Hwu | Medicine and Health Sciences | Lifetime achievement Award

Published on 20/06/202520/06/2025 by Research Hypothesis

Prof. Jih Ru Hwu | Medicine and Health Sciences | Lifetime achievement Award

Distinguished Chair Professor at National Tsing Hua University, Taiwan

Professor Reuben Jih-Ru Hwu is a Distinguished Chair Professor Emeritus with Lifetime Honor at National Tsing Hua University, Taiwan, and a globally recognized chemist whose career spans over four decades of pioneering research and academic excellence. Earning his Ph.D. from Stanford University in 1982, he served as a faculty member at Johns Hopkins University before returning to Asia, where he built an outstanding interdisciplinary research portfolio in drug design, DNA-cleaving agents, nano-biomaterials, organosilicon chemistry, natural product synthesis, and green chemistry. With over 253 publications and 52 patents, his contributions reflect both scientific rigor and practical innovation. Professor Hwu has been honored with numerous prestigious awards, including the TWAS Award, the Chinese American Chemical Society’s Outstanding Achievement Award, and the Taiwan National Chair Professorship. He is a Fellow of esteemed organizations such as TWAS, IUPAC, the Royal Society of Chemistry, and the European Academy of Sciences and Arts. His leadership roles, including presidencies of major chemical societies such as FACS and the Asian Federation for Medicinal Chemistry, further underscore his influential presence in the global scientific community.

Professional Profile

🎓 Education of Professor Reuben Jih-Ru Hwu

Professor Reuben Jih-Ru Hwu began his academic journey with a strong foundation in chemistry, culminating in a Ph.D. in Chemistry from the prestigious Stanford University in 1982. His doctoral training at Stanford equipped him with cutting-edge expertise in chemical research, setting the stage for his impactful scientific career. Prior to that, he demonstrated exceptional academic promise, which was later recognized through multiple international awards and fellowships. His educational background reflects both academic excellence and a commitment to innovation, shaping him into a global leader in multidisciplinary chemical sciences.

💼 Professional Experience of Professor Reuben Jih-Ru Hwu

Professor Reuben Jih-Ru Hwu has had a distinguished professional career marked by academic leadership, research excellence, and international collaboration. After earning his Ph.D. from Stanford University in 1982, he began his academic tenure as a faculty member at Johns Hopkins University, where he served from 1982 to 1991. He later returned to Taiwan and became a Distinguished Chair Professor at National Tsing Hua University, where he was eventually honored as Professor Emeritus with Lifetime Honor. Throughout his career, Professor Hwu has led groundbreaking research across diverse areas such as medicinal chemistry, nano-biomaterials, green chemistry, and synthetic methodology. He has also held key leadership roles in international scientific organizations, including serving as President of the Chinese American Chemical Society, the Asian Federation for Medicinal Chemistry, and the Federation of Asian Chemical Societies, demonstrating his global impact and commitment to advancing chemical sciences worldwide.

🔬 Research Interests of Professor Reuben Jih-Ru Hwu

Professor Reuben Jih-Ru Hwu’s research interests span a broad and impactful spectrum of chemical sciences, reflecting his passion for innovation and interdisciplinary exploration. His work encompasses drug design and synthesis, the development of DNA-cleaving agents, and the creation of advanced nano-biomaterials for biomedical applications. He has made significant contributions to natural product synthesis, organosilicon chemistry, and the discovery of novel chemical reactions and reagents. In recent years, Professor Hwu has also focused on sustainability and green chemistry, aiming to develop eco-friendly chemical processes. His diverse and forward-looking research not only advances scientific knowledge but also addresses critical global challenges in health, environment, and technology.

🏅 Awards and Honors of Professor Reuben Jih-Ru Hwu

Professor Reuben Jih-Ru Hwu has received numerous prestigious awards and honors that reflect his outstanding contributions to the chemical sciences. Notable recognitions include the 2023 Outstanding Achievement Award from the Chinese American Chemical Society, the Gulf Chemistry Association Trophy (2022), and the CAS Registry Innovator Award (2022). He has also been honored with the Taiwan National Chair Professorship, the TWAS Award (1997), and was named one of the JCI Ten Outstanding Young Persons of the World (1994). Earlier in his career, he received the FACS Distinguished Young Chemist Award (1992–93), the Alfred P. Sloan Research Fellowship (1986–1990), and the Stuart Pharmaceuticals Achievement Award (1986). His accolades span decades and continents, highlighting his influence in both academic and applied chemistry. These awards are a testament to his innovation, leadership, and lifelong dedication to advancing science.

✅Conclusion

Professor Reuben Jih-Ru Hwu is a highly qualified and exceptional candidate for the Best Researcher Award. His prolific academic output, international recognitions, scientific leadership, and broad research contributions place him among the top-tier scientists in the field of chemistry and interdisciplinary sciences. With slight enhancement in showcasing his recent impactful contributions and societal influence, his nomination would not only be justified but compelling on a global scale.

📚 Publications

1. Calcium Impregnated Silica Gel in the Domino Reaction Involving Irreversible Aldol Addition, Dehydration, and Michael Addition

Title: Calcium Impregnated Silica Gel in the Domino Reaction Involving Irreversible Aldol Addition, Dehydration, and Michael AdditionAuthors: Jih Ru Hwu, Khagendra Prasad Bohara, Mohit Kapoor, et al. (with collaborators from National Tsing Hua University and affiliated institutes)
Journal: Journal of Organic Chemistry
Year: 2025 (published ~2 months ago from June 2025)
Citations: 0

2. 6‑Chlorocoumarin Conjugates with Nucleobases and Nucleosides as Potent Anti‑Hepatitis C Virus Agents

Title: 6‑Chlorocoumarin Conjugates with Nucleobases and Nucleosides as Potent Anti‑Hepatitis C Virus Agents
Authors: Shu‑Yu Lin, Wen‑Chieh Huang, Shwu‑Chen Tsay, Johan Neyts, Pieter Leyssen, Chun‑Cheng Lin, Kuo Chu Hwang, Jia‑Cherng Horng, and Jih Ru Hwu
Journal: Molecules (Open access)
Year: 2025 (Volume 30, Issue 8, Article 1776)
Citations: 0

Yashwant Pathak | Medicine and Health Sciences | Best Researcher Award

Published on 18/06/202518/06/2025 by Research Hypothesis

Prof. Yashwant Pathak | Medicine and Health Sciences | Best Researcher Award

Professor at Univ of South Florida Taneja College of Pharmacy, United States

Professor Yashwant V. Pathak is a globally renowned pharmaceutical scientist, educator, and research leader with a distinguished academic and international career spanning over four decades. Currently serving as Associate Dean and Full Professor at the University of South Florida’s Taneja College of Pharmacy, he has made groundbreaking contributions in nanotechnology, drug delivery systems, nutraceuticals, and healthcare education. A recipient of prestigious honors such as the Fellowship of the American Association for the Advancement of Science (AAAS) and multiple Fulbright Fellowships, Dr. Pathak has conducted postdoctoral research at elite institutions and lectured in over 100 universities across 80+ countries. His scholarly output exceeds 5,200 citations with an h-index of 33, and he has authored and edited numerous influential books, including the award-winning Handbook of Space Pharmaceuticals. With significant roles in research leadership, global collaborations, and interdisciplinary education, Professor Pathak exemplifies the highest standards of innovation, academic excellence, and global impact in science.

Professional Profile

Google Scholar

🎓 Educational Journey of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak’s educational background reflects a dynamic fusion of science, management, and interdisciplinary expertise. He began his academic journey with a Bachelor of Pharmacy (B.Pharm, 1975) and a Master of Pharmacy (M.Pharm, 1977) in Pharmaceutical Technology from Nagpur University, India, laying a strong foundation in pharmaceutical sciences. He further advanced his specialization by earning a Ph.D. in Pharmaceutical Sciences (1989) from the same institution. Demonstrating a commitment to leadership and holistic development, he pursued an Executive MBA in Business Management (2009) and a Master of Science in Conflict Management (MSCM, 2010) from Sullivan University, USA, graduating Summa Cum Laude in both programs. This diverse educational portfolio has empowered Dr. Pathak with a rare blend of technical expertise, strategic thinking, and conflict resolution—making him a uniquely qualified academic leader and international research collaborator.

💼 Professional Experience of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak brings over four decades of rich and diverse professional experience across academia, industry, and global research institutions. Currently serving as Associate Dean for Faculty Affairs and Full Professor at the University of South Florida (USF), he has held key leadership roles including Chair of International Working Groups and Director of Nanotechnology Centers. His previous appointments include Assistant Dean for Research and Graduate Programs at Sullivan University, USA, and Director of R&D at Neos Therapeutics, Texas, reflecting his strong industry-academia interface. He has also served as a pharmaceutical consultant for international tech transfer and worked as a postdoctoral fellow and visiting scientist at esteemed global institutions including the University of Michigan (USA), Hebrew University (Israel), and Royal Free Hospital (UK). His expertise spans pharmaceutical R&D, academic administration, and interdisciplinary collaborations, and he has made significant contributions to institutional growth, research innovation, and global education.

🔬 Research Interests of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak’s research interests are at the forefront of interdisciplinary science, spanning nanotechnology-based drug delivery systems, pharmaceutical innovations, nutraceuticals, and space pharmaceuticals. His pioneering work in nanomedicine and siRNA delivery technologies has positioned him as a global authority in targeted and controlled drug delivery mechanisms. He is deeply engaged in exploring the impact of microgravity on drug formulations, contributing significantly to the emerging field of space pharmacology. Additionally, Dr. Pathak’s interest in artificial intelligence in healthcare, conflict management in scientific collaborations, and the development of functional foods and nutraceuticals demonstrates his commitment to integrating science with global health and policy challenges. His multidisciplinary approach not only advances pharmaceutical sciences but also addresses broader health and sustainability issues on an international scale.

🏆 Awards and Honors of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak has been the recipient of numerous prestigious national and international awards that reflect his outstanding contributions to science, education, and global collaboration. Most notably, he is a Fellow of the American Association for the Advancement of Science (AAAS), one of the highest honors in the scientific community. He has received four Fulbright Fellowships across countries such as Indonesia, South Africa, Colombia, and the Czech Republic—recognizing his expertise in nanotechnology and pharmaceutical sciences. His book Handbook of Space Pharmaceuticals received the Book of the Year Award (2022) from the International Academy of Aeronautics. He has also been honored with fellowships and grants from government agencies in Australia, Brazil, Ecuador, China, Nigeria, and the USA, including the Endeavour Executive Fellowship, CNPQ Fellowship, and Mandela Washington Fellowship. At the University of South Florida, he has been repeatedly recognized with Outstanding Faculty Awards, a Global Engagement Achievement Award, and the USF Outstanding Research Faculty Award, underscoring his leadership in academia and research.

🏁 Conclusion

His global impact, interdisciplinary leadership, prolific scholarly output, and academic excellence firmly position him as a trailblazer in pharmaceutical sciences and allied fields. His contributions reflect not only intellectual brilliance but also a deep commitment to global scientific collaboration and education.

📚 Publications of Jibamitra Ganguly

1. Title: CAR T cells in solid tumors: challenges and opportunities
Authors: F. Marofi, R. Motavalli, V.A. Safonov, L. Thangavelu, A.V. Yumashev, …
Year: 2021
Citations: 611

2. Title: Nanoparticulate drug-delivery systems: an overview
Authors: D. Thassu, Y. Pathak, M. Deleers
Year: 2007
Citations: 349

3. Title: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
Authors: A. Markov, L. Thangavelu, S. Aravindhan, A.O. Zekiy, M. Jarahian, …
Year: 2021
Citations: 310

4. Title: A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine
Authors: S. Moghadasi, M. Elveny, H.S. Rahman, W. Suksatan, A.T. Jalil, …
Year: 2021
Citations: 279

5. Title: Drug delivery nanoparticles formulation and characterization
Authors: Y. Pathak, D. Thassu
Year: 2009
Citations: 224

6. Title: Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
Authors: F. Marofi, H.S. Rahman, Z.M.J. Al-Obaidi, A.T. Jalil, W.K. Abdelbasset, …
Year: 2021
Citations: 195

7. Title: Polyacrylate (Eudragit retard) microspheres for oral controlled release of nifedipine. I. Formulation design and process optimization
Authors: A. Barkai, Y.V. Pathak, S. Benita
Year: 1990
Citations: 169

8. Title: Ocular drug delivery: impact of in vitro cell culture models
Authors: A. Solanki, S. Desai, A. Grover, A. Hirani, Y. Pathak, V. Sutariya
Year: 2016
Citations: 165

9. Title: Surface modification of nanoparticles for targeted drug delivery
Authors: P. Patel, A. Hanini, A. Shah, D. Patel, S. Patel, P. Bhatt, Y.V. Pathak
Year: 2019
Citations: 139

10. Title: Targeting nanoparticles as drug delivery systems for cancer treatment
Authors: K. Subramani, H. Hosseinkhani, A. Khraisat, M. Hosseinkhani, Y. Pathak
Year: 2009
Citations: 112

Jim Sheu | Medicine and Health Sciences | Hypothesis Achievement Award

Published on 03/05/202503/05/2025 by Research Hypothesis

Jim Sheu | Medicine and Health Sciences | Hypothesis Achievement Award

Prof Jim Sheu, National Sun Yatsen University, Taiwan

Prof. Jim Sheu is a distinguished biomedical scientist with over two decades of academic and research excellence in life sciences. Holding a Ph.D. in Life Science from National Tsing-Hua University (2002), he has consistently advanced the frontiers of molecular oncology, stem cell therapy, and women’s reproductive health. Currently a professor at National Sun Yat-sen University, Taiwan, he has previously held prestigious research and academic positions at China Medical University and Johns Hopkins Medical Institutions. He is widely recognized for his role in leading innovative biomedical projects and mentoring the next generation of scientists. Prof. Sheu has made pioneering contributions to cancer genomics, glioblastoma therapeutics, and endometriosis research. His prolific publication record and multiple awards underline his leadership and innovation in the field. His work bridges translational research with clinical applications, shaping modern therapeutic strategies.

Publication Profile

Google Scholar

Education

Prof. Jim Sheu’s educational journey laid a strong foundation for his impactful scientific career. He earned his Ph.D. in Life Science from the prestigious National Tsing-Hua University, Taiwan, in 2002 🧬. This doctoral training provided him with deep expertise in molecular biology, genetics, and biomedical research. Prior to that, he completed his B.S. in Biology from Fu-Jen University, Taiwan, in 1994 🧪. The rigorous academic environment at these institutions honed his critical thinking and experimental skills. His thesis and postdoctoral work involved advanced molecular techniques and translational research applications. With education deeply rooted in cellular biology and medical biotechnology, Prof. Sheu has seamlessly integrated his academic background with real-world research, evolving into a leading expert in cancer biology, stem cell therapies, and women’s health. His academic excellence has continued to inspire his students and collaborators across various institutes.

Experience

Prof. Sheu’s career spans academia, clinical research, and biotechnology. Since 2014, he has served as Professor at the Institute of Biomedical Sciences, National Sun Yat-sen University 🏫. Previously, he held multiple roles at China Medical University (2006–2014), including Researcher, Professor, Associate Professor, and Assistant Professor in the Graduate Institute of Chinese Medical Science 🧑‍🏫. His early international experience includes being a Research Fellow at Johns Hopkins Medical Institutions (2004–2006) 🔬. He also held leadership positions at Taiwan’s Development Center for Biotechnology (2003–2004), directing and managing key protein drug and biomedicine projects. His academic and research trajectory is marked by interdisciplinary innovation, integrating biomedical engineering, genetics, and pharmacology. Prof. Sheu’s deep involvement in translational research and collaborative initiatives underpins his reputation as a scientific leader in Taiwan and beyond.

Awards & Honors

Prof. Sheu has earned several prestigious honors celebrating his research excellence and innovation. In 2023, he was part of the award-winning Biomedical Team at National Sun Yat-sen University for a serum-free stem cell medium at the NBRP Pitch Day 🧫🏅. He also received the Outstanding Faculty of Basic Research award and the Tien-Te Lee Award for an outstanding poster on stem cell therapies for Parkinson’s disease. In 2022, he was honored by the Taiwan Endometriosis Society for his research using traditional medicine to modulate immune responses 🌿🧠. Additionally, he won the Prof. Chii-Ruey Tzeng Award for an impactful paper in endometriosis research. These accolades highlight Prof. Sheu’s interdisciplinary impact, bridging traditional Chinese medicine, molecular biology, and cutting-edge therapeutic development. His continuous recognition by scientific communities underscores his leadership in biomedical innovation.

Research Projects

Prof. Jim Sheu has actively contributed as a project reviewer in the field of life sciences since 2012 🌱. He serves the National Science and Technology Council (NSTC) in Taiwan and has reviewed projects for various institutions including Tri-Service General Hospital (2021–present), Kaohsiung Veterans General Hospital (2021–present), and Zuoying Armed Forces General Hospital (2020–present) 🏥. He also evaluated projects for National Tsing-Hua University (2023) and Kaohsiung Chang Gung Smart Hospital (2022) 🎓. His expertise has extended globally, reviewing for Italy’s Ministry of Health in 2015 🇮🇹 and South Africa’s Medical Research Council in 2012 🇿🇦, showcasing his international recognition 🌍.

Research Focus

Prof. Sheu’s research is centered on cancer biology, stem cell therapy, gynecological diseases, and translational medicine. He explores the molecular mechanisms of tumor progression, particularly in microsatellite instability and glioblastoma 🔍🧠. His investigations into ethnic-specific genetic markers for endometriosis and ovarian aging highlight his commitment to personalized medicine. Another focus lies in the regulation of immune responses using traditional herbal compounds, bridging modern molecular science with Eastern medicine 🌿🧪. He has led multi-omics studies that decode complex disease pathways, including mitochondrial dysfunction in breast cancer. Additionally, he is advancing serum-free stem cell enhancement technologies aimed at clinical application. Prof. Sheu’s interdisciplinary approach links genomics, proteomics, and pharmacology, translating basic research into viable therapeutic strategies. His work significantly contributes to understanding cellular aging, reproductive biology, and cancer therapy.

Publication Top Notes

Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma

Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma

A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival

Puerariae radix isoflavones and their metabolites inhibit growth and induce apoptosis in breast cancer cells

Autophagy and its link to type II diabetes mellitus

Talin‐1 overexpression defines high risk for aggressive oral squamous cell carcinoma and promotes cancer metastasis

Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins

Amirsina Sharifi | Medicine and Health Sciences | Best Researcher Award

Published on 18/02/202518/02/2025 by Research Hypothesis

Amirsina Sharifi | Medicine and Health Sciences | Best Researcher Award

Dr Amirsina Sharifi, Cancer Institute, Iran

Dr. Amirsina Sharifi 🏥🔬 is a board-certified general surgeon specializing in trauma and surgical oncology. He earned his M.D. and completed his residency at Tehran University of Medical Sciences 🎓. With experience as a general surgeon at Shafa Hospital and Ziaeian Hospital, he actively contributes to surgical research at Sina Trauma and Surgery Research Center and the Cancer Institute Research Center. His expertise spans epidemiology, surgical interventions, and molecular biology 🧬. A prolific researcher, he has numerous publications in high-impact journals. Ranked 7th in Iran’s national entrance exam, he is a dedicated educator and a member of prestigious medical organizations 🏆📚.

Publication Profile

Google Scholar

Education

Dr. Amirsina Sharifi is a dedicated general surgeon 🏥 with a strong academic background from Tehran University of Medical Sciences 🎓. He completed his medical school studies (2009 – 2015) and pursued an internship (2015 – 2017) at the same institution, gaining extensive hands-on experience. Dr. Sharifi then specialized in general surgery through a rigorous residency program (2018 – 2022) 🔬. His expertise was solidified when he achieved board certification in general surgery in September 2022 🏆. With years of training and a passion for patient care, he continues to contribute to the medical field with skill and dedication 💉.

Experience

Dr. Amirsina Sharifi is a dedicated medical professional 🩺 with extensive experience in general surgery and research. He began his career as a General Practitioner at Shafa Hospital, Birjand University of Medical Sciences (July 2017 – August 2018) in South Khorasan, Iran. Later, he served as a General Surgeon at Shafa Hospital, Kurdestan University of Medical Sciences (October 2022 – March 2024) in Saqqez, Kurdestan, Iran. Since April 2024, he has been practicing at Ziaeian Hospital, Tehran University of Medical Sciences. Alongside his clinical work, he has been a Research Associate at Sina Trauma and Surgery Research Center (since May 2015) and the Cancer Institute Research Center (since August 2018) at Tehran University of Medical Sciences 🔬📚.

Workshops and Certifications

Dr. Amirsina Sharifi has pursued extensive professional development through specialized workshops and certifications 🎓. He has successfully completed Advanced Trauma Life Support 🚑, Cardiopulmonary Resuscitation ❤️, Research Methodology 📊, and Scientific Writing ✍️ at Tehran University of Medical Sciences 🏥. These achievements reflect his dedication to both clinical excellence and academic research, enhancing his expertise in emergency care and scholarly contributions 📖. His commitment to continuous learning ensures he stays at the forefront of medical advancements, equipping him with the skills to provide high-quality patient care while also contributing to the scientific community 🔬.

Teaching and Mentorship

Dr. Amirsina Sharifi is deeply committed to medical education, playing a vital role in shaping future healthcare professionals 👨‍⚕️📚. He conducts monthly surgical training sessions 🏥✂️, providing hands-on experience to aspiring surgeons. Additionally, he delivers weekly lectures on disease management, ensuring students gain comprehensive medical knowledge 🧑‍⚕️📖. His dedication to mentoring and guiding undergraduates reflects his passion for teaching and expertise in the field 🎓💡. Through his continuous efforts, Dr. Sharifi contributes significantly to the advancement of medical education and the development of skilled healthcare practitioners 💉🔬.

Awards and Honors

Dr. Amirsina Sharifi 🎓🏅 achieved an outstanding academic milestone by securing 7th place among 3.7 million candidates in Iran’s national university entrance exam 📚✨. As a distinguished member of Tehran University’s Exceptional Talent Development Center 🎖️, he has demonstrated excellence in academia and research. Dr. Sharifi is actively affiliated with the Iranian Association of Surgeons 🏥🔬 and the Iranian Medical Council ⚕️, contributing to the advancement of medical sciences. His dedication to surgical excellence and professional development continues to shape his impactful career in the medical field 🏆👨‍⚕️.

Research Focus

Dr. Amirsina Sharifi’s research primarily focuses on public health, environmental medicine, and clinical surgery 🏥🌍. His studies examine the health effects of air pollution 🌫️ on disease risk, obesity treatments like laparoscopic gastric procedures ⚕️, and the management of deep neck abscesses using ultrasound-guided techniques. Additionally, he has explored non-alcoholic fatty liver disease 🍏, emergency medicine approaches for acute abdominal pain 🤕, and autism awareness among healthcare professionals 🧠. His work also includes home-based rehabilitation 🏡 for spinal cord injuries, emphasizing patient-centered recovery. Overall, his research spans environmental health, surgery, and rehabilitation medicine for improved healthcare outcomes. ✅